This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2015 Jun;172(6):1680-1682.

doi: 10.1111/bjd.13610. Epub 2015 Apr 19.

Oral squamous cell carcinoma and hyperkeratotic lesions with BRAF inhibitors

E Vigarios^{1

2}, L Lamant³, J P Delord⁴, J C Fricain^{5

6}, C Chevreau⁴, B Barrés³, C Gomez-Roca⁴, M Boulanger^{1

2}, V Sibaud⁷

Affiliations

Affiliations

¹ Oral Oncology Department, Institut Claudius Regaud, Institut Universitaire du Cancer, Toulouse Oncopole, 1 av Irène Joliot-Curie, 31059, Toulouse CEDEX 9, France.
² UFR Odontologie, 3 Chemin des Maraîchers, 31062, Toulouse CEDEX 9, France.
³ Pathology Department, Institut Claudius Regaud, Institut Universitaire du Cancer, Toulouse Oncopole, 1 av Irène Joliot-Curie, 31059, Toulouse CEDEX 9, France.
⁴ Oncology Department, Institut Claudius Regaud, Institut Universitaire du Cancer, Toulouse Oncopole, 1 av Irène Joliot-Curie, 31059, Toulouse CEDEX 9, France.
⁵ Oral Medicine Department, Pôle Odontologie et Santé Buccale, Hôpital Pellegrin, Place Amélie-Raba-Léon, 33076, Bordeaux CEDEX, France.
⁶ UFR Odontologie Bordeaux, 16-20 Cours de la Marne, 33076, Bordeaux CEDEX, France.
⁷ Dermatology Department, Institut Claudius Regaud, Institut Universitaire du Cancer, Toulouse Oncopole, 1 av Irène Joliot-Curie, 31059, Toulouse CEDEX 9, France.

PMID: 25495246
DOI: 10.1111/bjd.13610

Oral squamous cell carcinoma and hyperkeratotic lesions with BRAF inhibitors

E Vigarios et al. Br J Dermatol. 2015 Jun.

. 2015 Jun;172(6):1680-1682.

doi: 10.1111/bjd.13610. Epub 2015 Apr 19.

Authors

E Vigarios^{1

2}, L Lamant³, J P Delord⁴, J C Fricain^{5

6}, C Chevreau⁴, B Barrés³, C Gomez-Roca⁴, M Boulanger^{1

2}, V Sibaud⁷

Affiliations

¹ Oral Oncology Department, Institut Claudius Regaud, Institut Universitaire du Cancer, Toulouse Oncopole, 1 av Irène Joliot-Curie, 31059, Toulouse CEDEX 9, France.
² UFR Odontologie, 3 Chemin des Maraîchers, 31062, Toulouse CEDEX 9, France.
³ Pathology Department, Institut Claudius Regaud, Institut Universitaire du Cancer, Toulouse Oncopole, 1 av Irène Joliot-Curie, 31059, Toulouse CEDEX 9, France.
⁴ Oncology Department, Institut Claudius Regaud, Institut Universitaire du Cancer, Toulouse Oncopole, 1 av Irène Joliot-Curie, 31059, Toulouse CEDEX 9, France.
⁵ Oral Medicine Department, Pôle Odontologie et Santé Buccale, Hôpital Pellegrin, Place Amélie-Raba-Léon, 33076, Bordeaux CEDEX, France.
⁶ UFR Odontologie Bordeaux, 16-20 Cours de la Marne, 33076, Bordeaux CEDEX, France.
⁷ Dermatology Department, Institut Claudius Regaud, Institut Universitaire du Cancer, Toulouse Oncopole, 1 av Irène Joliot-Curie, 31059, Toulouse CEDEX 9, France.

PMID: 25495246
DOI: 10.1111/bjd.13610

No abstract available

PubMed Disclaimer

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program